Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/02/031077
CTRI/2021/02/031077
Not yet recruiting
未知

A prospective, randomized controlled trial to compare the outcomes of same day discharge vs Day - 3 discharge following cardiac implantable electronic device implantation

PGIMER CHANDIGARH0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: I442- Atrioventricular block, completeHealth Condition 2: I420- Dilated cardiomyopathyHealth Condition 3: I453- Trifascicular block

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: I442- Atrioventricular block, completeHealth Condition 2: I420- Dilated cardiomyopathyHealth Condition 3: I453- Trifascicular block
Sponsor
PGIMER CHANDIGARH
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •All adult patients ( \>18 years old) with indication to CIED implantation according to contemporary guidelines

Exclusion Criteria

  • •1\.CIED replacement or upgrading,
  • •2\.Cardiac resynchronization therapy (CRT) device implantation,
  • •3\.Disabling conditions causing physical and mobility impairment (e.g. severe muscular dystrophies, spinal cord lesions)
  • •4\.Autoimmune diseases,
  • •5\.Antibiotic use for any reason (including patients who were chronically immunocompromised),
  • •6\.Any surgery within the prior 30 days,
  • •7\.Previous infection treated in the prior 30 days,
  • •8\.Other antibiotic prophylaxis indications (eg, patients with prosthetic heart valves)
  • •9\.Hemodynamically unstable, intubated patients
  • •10\.Patients with major intra\-procedural complications such as pneumothorax, cardiac perforation/pericardial tamponade, haemothorax, myocardial infarction, peripheral embolus, stroke, and deat

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
A prospective, randomized, controlled trial to compare the effectiveness of endoscopic sphincterotomy with endoscopic papillary large balloon dilation for removal of bile duct stonesbile duct stones, ductal stones
JPRN-UMIN000013887Kansai Endoscopic Device Selection (EDS) Working Group60
Completed
Not Applicable
Study to compare the clinical outcomes of coiled-end versus straight-end Swan-Neck peritoneal dialysis (PD) cathetersEnd stage renal disease requiring renal replacement therapyUrological and Genital DiseasesEnd-stage renal disease
ISRCTN05846916Shanghai Ruijin Hospital, Shanghai Jiaotong University, School of Medicine (China)80
Completed
Not Applicable
Optimal Duration of Adductor Canal Catheter Infusions for analgesia following Knee Arthroplasty
ACTRN12616000610437The Joint Studio64
Not yet recruiting
Phase 1
A study to compare the effectiveness and safety of different doses of a drug clonidine when used along with a drug bupivacaine in spinal anesthesiaHealth Condition 1: S729- Unspecified fracture of femurHealth Condition 2: S929- Unspecified fracture of foot and toeHealth Condition 3: S829- Unspecified fracture of lower leg
CTRI/2019/05/019341J J hospital
Recruiting
Phase 3
Effectiveness of Tissue plasminogen activator (TPA) for treatment of ARDS induced by Covid-19COVID-19.COVID-19 induced ARDSU07.1
IRCT20200415047080N1Tehran University of Medical Sciences30